Restoring Emotional Wellbeing

The family and societal impact of serious mental illness and neurodegenerative diseases continues to grow.


At Epiodyne, our mission is to improve the lives of patients, families, and communities by bringing to market new products to treat neurobehavioral symptoms of brain disorders.

A Growing Crisis

The emotional and economic cost of brain disorders in the US is high and growing. We believe there is a major unmet need to alleviate the heavy burden created by emotional and behavioral symptoms of these disorders. New, effective treatments are needed.

1 in 25 Adults

Americans suffering from serious mental illness1


Percentage of patients with obsessive compulsive disorder do not respond to available treatments2

4-6 Million

Americans living with opioid use disorder3

14 Million

The projected number of Americans living with Alzheimer’s disease by the year 20504

At Epiodyne, we are focused on creating better molecules to treat these debilitating disorders.